Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)

NAActive, not recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 12, 2019

Primary Completion Date

December 22, 2021

Study Completion Date

June 30, 2026

Conditions
Coronary Artery Disease
Interventions
DEVICE

Device: Paclitaxel-Coated PTCA Balloon Catheter

Percutaneous Transluminal Coronary Angioplasty

DEVICE

SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel

Percutaneous Transluminal Coronary Angioplasty

Trial Locations (14)

802-8555

Kokura Memorial Hospital, Kitakyushu

065-0033

Sapporo Higashi Tokushukai Hospital, Sapporo

211-8510

Japan Labour Health and Welfare Organization Kanto Rosai Hospital, Kawasaki

247-8533

Shonan Kamakura General Hospital, Ōfuna

230-8765

Saiseikai Yokohama-City Eastern Hospital, Yokohama

980-0873

Sendai Kousei Hospital, Sendai

530-0012

Osaka Saiseikai Nakatsu Hospital, Kita

153-8515

Toho University Ohashi Medical Center, Meguro City

142-8666

Showa Medical University Hospital, Shinagawa-Ku

162-8666

Tokyo Women's Medical University Hospital, Shinjuku-Ku

173-8606

Teikyo University Hospital, tabashi City

615-8256

Kyoto-Katsura Hospital, Kyoto

880-0834

Miyazaki Medical Association Hospital, Miyazaki

530-0001

Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY